4//SEC Filing
WIKLER MATTHEW 4
Accession 0001493152-22-032691
CIK 0001582554other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 9:33 PM ET
Size
5.6 KB
Accession
0001493152-22-032691
Insider Transaction Report
Form 4
WIKLER MATTHEW
Director
Transactions
- Award
Stock option (right to buy)
2022-11-14+142,657→ 142,657 totalExercise: $0.73Exp: 2032-11-14→ Common Stock (142,657 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on November 14, 2022. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001195414
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 9:33 PM ET
- Size
- 5.6 KB